GENB
Generate Biomedicines, Inc. • NASDAQ
$13.45 ▲ 6.28% (+0.80)
GENB
Generate Biomedicines, Inc.NASDAQ • $13.45 ▲ 6.28% (+0.80)
Market Cap $316.25 M
52w High $15.32
52w Low $11.44
P/E 0
Volume 6.22M
Outstanding Shares 25.00M
Market Cap $316.25 M
52w High $15.32
52w Low $11.44
P/E 0
Volume 6.22M
Outstanding Shares 25.00M
About Generate Biomedicines, Inc.
https://generatebiomedicines.comGenerate Biomedicines, Inc., engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics in the United States. It uses protein-based modalities for drug development.
CEO
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Asset Management
Sector Financial Services
Went public February 27, 2026
Method of going public IPO
Full time employees 0
Price Target
Target High $0
Target Low $0
Target Median $0
Target Consensus $0